Search results for "Highlights"
Review examines drugs, lifestyle treatments for NAFLD
The umbrella review included 27 meta-analyses of randomized controlled trials examining the effectiveness of pharmacological interventions and lifestyle modifications, including diet and exercise, for patients with nonalcoholic fatty liver disease (NAFLD).
https://gastroenterology.acponline.org/archives/2022/05/27/2.htm
27 May 2022
AGA issues guidance on drug treatment for patients with IBS
Two new clinical practice guidelines from the American Gastroenterological Association (AGA) provide recommendations on the use of medications to treat irritable bowel syndrome (IBS) with constipation and IBS with diarrhea.
https://gastroenterology.acponline.org/archives/2022/06/24/1.htm
24 Jun 2022
H. pylori eradication therapy may lead to better outcomes for functional dyspepsia
A systematic review and meta-analysis found that Helicobacter pylori eradication therapy was associated with higher cure rates and rates of symptom improvement in H. pylori-positive patients with functional dyspepsia.
https://gastroenterology.acponline.org/archives/2022/01/28/2.htm
28 Jan 2022
Spotlight on Helicobacter pylori treatment
A review found that susceptibility-guided therapy may be the superior first-line treatment for H. pylori infection in areas with high antibiotic resistance, while a study of trial participants with 26.5 years of follow-up showed that H. pylori eradication may provide long-term protection against gastric cancer.
https://gastroenterology.acponline.org/archives/2022/04/22/5.htm
22 Apr 2022
Transportation, patient education among factors affecting colonoscopy rates after abnormal FIT, survey finds
Primary care physicians and staff were asked to identify patients' barriers to completing colonoscopy after an abnormal fecal immunochemical test (FIT) result, as well as factors that made completion more likely.
https://gastroenterology.acponline.org/archives/2021/08/27/2.htm
27 Aug 2021
Patient navigation associated with increased care, treatment in hepatitis C
A pre-post study in a safety-net health system found higher odds of linkage to care and direct-acting antiviral treatment in older adults who received patient navigation rather than usual care.
https://gastroenterology.acponline.org/archives/2022/05/27/3.htm
27 May 2022
NAFLD progression associated with increased mortality risk
Patients with stage F4 nonalcoholic fatty liver disease (NAFLD) have significantly increased risk for liver-related complications, type 2 diabetes, and all-cause mortality compared to those with earlier stages, an observational prospective study found.
https://gastroenterology.acponline.org/archives/2021/10/22/3.htm
22 Oct 2021
DPP-4 inhibitors associated with risk of cholecystitis, meta-analysis finds
Patients with type 2 diabetes who were randomized to receive dipeptidyl peptidase-4 (DPP-4) inhibitors had higher rates of gallbladder disease than those who got placebo or nonincretin drugs, but no difference in risk of cholelithiasis or biliary diseases.
https://gastroenterology.acponline.org/archives/2022/07/22/6.htm
22 Jul 2022
Self-administered questionnaire may help evaluate patients' cirrhosis knowledge
The questionnaire, which covered medication use and accessibility, medication obstacles, lactulose use, diuretic use, beta-blocker use, and dietary sodium use, was validated in a study of 582 outpatients and 131 inpatients.
https://gastroenterology.acponline.org/archives/2022/09/23/1.htm
23 Sep 2022
U.S. sees increase in alcohol-associated liver disease mortality
Deaths from alcohol-associated liver disease increased among men and women, across all ages, and in all racial/ethnic populations in the U.S. from 2017 through 2020, leading researchers to call for a nationwide effort to reduce national alcohol consumption, improve screening, and optimize early treatment.
https://gastroenterology.acponline.org/archives/2022/03/25/2.htm
25 Mar 2022